Clesrovimab in Infants at Increased Risk For Severe Disease During 2 RSV Seasons

Heather J. Zar, Louis J. Bont, Paolo Manzoni, Flor M. Muñoz, Octavio Ramilo, Po-Yen Chen, José M Novoa, Gustavo A. Ordoñez, Maria Tsolia, Bruce Tapiéro, Mirta I. Acuña-Ávila, Javier M. Castellanos, Michael Meyer, Ichiro Morioka, Santtu Heinonen, Ziqiang Chen, Tiantian Zeng, Radha A. Railkar, Carmen · 2026

Read Clesrovimab in Infants at Increased Risk For Severe Disease During 2 RSV Seasons by Heather J. Zar, Louis J. Bont, Paolo Manzoni, Flor M. Muñoz, Octavio Ramilo, Po-Yen Chen, José M Novoa, Gustavo A. Ordoñez, Maria Tsolia, Bruce Tapiéro, Mirta I. Acuña-Ávila, Javier M. Castellanos, Michael Meyer, Ichiro Morioka, Santtu Heinonen, Ziqiang Chen, Tiantian Zeng, Radha A. Railkar, Carmen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13386298.txt.

Description

Heather Zar and a large study group report a trial of a long-acting antibody to shield high-risk infants from RSV across two seasons. Their randomized trial was published in twenty twenty-six. The virus is a leading cause of severe chest disease in babies.

The antibody, clesrovimab, is approved for a baby's first RSV season. This trial compared it with the older antibody palivizumab in season one for infants at raised risk. Children still at risk got a higher dose in season two. Safety and tolerance were the main questions, with drug levels and disease rates also tracked. The design was partly masked and randomized. Results from the second season guide how long protection should be extended for fragile children.

Catalog record

CREATORHeather J. Zar, Louis J. Bont, Paolo Manzoni, Flor M. Muñoz, Octavio Ramilo, Po-Yen Chen, José M Novoa, Gustavo A. Ordoñez, Maria Tsolia, Bruce Tapiéro, Mirta I. Acuña-Ávila, Javier M. Castellanos, Michael Meyer, Ichiro Morioka, Santtu Heinonen, Ziqiang Chen, Tiantian Zeng, Radha A. Railkar, Carmen
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13386298

Browse the full library · About the Tower of Babel